InvestorsHub Logo
Followers 37
Posts 6069
Boards Moderated 1
Alias Born 08/07/2018

Re: None

Sunday, 03/10/2019 9:27:09 PM

Sunday, March 10, 2019 9:27:09 PM

Post# of 332531
BIEL is not that far from profitability. Expectations with financials are historically low which is baked in to the current pps .Would not take much of an increase in revenue to provide BIEL with a significant tail wind. Increase revenues are likely due increased domestic sales via CVS assuming these sales are reflected in Q4. Increased sales in the U.K. ( just look at the demand reflected by the hundreds of posts of enthusiastic users on Actipatch FB ) also distribution fees from Mundipharma is figured in overall revenue and will be reflected in the financials. I think the Q4 report will be a positive surprise considering all the obstacles for BIEL.
$BIEL$$$